Lifecare ASA financials
Lifecare ASA
254900D88MYGZ7JD5P39 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | NOK 3.0M | NOK 4.3M |
| Other income | NOK 6.6M | NOK 8.8M |
| Operating expenses | NOK 94.5M | NOK 48.4M |
| Employee benefits expense | NOK 37.7M | NOK 25.7M |
| Depreciation & amortisation | NOK 4.9M | NOK 3.3M |
| Operating profit (EBIT) | -NOK 84.8M | -NOK 35.3M |
| Net finance income / (cost) | NOK 11.3M | NOK 26.0K |
| Finance costs | NOK 892.0K | NOK 980.0K |
| Profit before tax | -NOK 73.5M | -NOK 35.3M |
| Income tax expense | -NOK 740.0K | -NOK 116.0K |
| Profit for the year | -NOK 72.7M | -NOK 35.2M |
| — attributable to owners | -NOK 71.8M | -NOK 35.3M |
| — attributable to NCI | -NOK 987.0K | NOK 52.0K |
| Total comprehensive income | -NOK 73.1M | -NOK 35.3M |
| Per share | ||
| Basic EPS | NOK -5.73 | NOK -3.81 |
| Diluted EPS | NOK -5.73 | NOK -3.81 |
| Free cash flow / share | NOK -6.17 | NOK -4.17 |
| Cash flow statement | ||
| Net cash from operating activities | -NOK 65.5M | -NOK 37.3M |
| Net cash from investing activities | -NOK 12.4M | -NOK 1.2M |
| Purchase of PP&E (capex) | NOK 12.8M | NOK 1.2M |
| Net cash from financing activities | NOK 91.2M | NOK 39.3M |
| Lease liability payments | NOK 1.6M | NOK 871.0K |
| Balance sheet | ||
| Total assets | NOK 112.6M | NOK 86.4M |
| Non-current assets | NOK 37.8M | NOK 22.3M |
| Property, plant & equipment | NOK 14.5M | NOK 3.2M |
| Right-of-use assets | NOK 10.7M | NOK 6.6M |
| Intangible assets & goodwill | NOK 7.2M | NOK 7.2M |
| Current assets | NOK 74.8M | NOK 64.0M |
| Trade & other receivables | NOK 2.2M | NOK 4.0M |
| Total equity | NOK 74.0M | NOK 66.5M |
| Non-current liabilities | NOK 9.2M | NOK 9.3M |
| Lease liabilities (non-current) | NOK 8.3M | NOK 4.7M |
| Current liabilities | NOK 29.4M | NOK 10.6M |
| Lease liabilities (current) | NOK 2.6M | NOK 1.7M |
| Deferred tax liabilities | NOK 923.0K | NOK 1.6M |
| Derived metrics | ||
| Free cash flow | -NOK 78.3M | -NOK 38.5M |
| Operating margin | -2797.2% | -829.4% |
| Net margin | -2400.0% | -826.0% |
| Return on equity | -98.3% | -53.0% |
| Cash conversion ratio | 0.90× | 1.06× |
| Capex coverage | -5.13× | -30.73× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense | NOK 4.9M | NOK 3.3M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | NOK 3.1M | NOK 3.7M |
| Cash | NOK 61.6M | NOK 48.3M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | -NOK 409.0K | NOK 0 |
| Comprehensive Income Attributable To Noncontrolling Interests | -NOK 987.0K | NOK 52.0K |
| Comprehensive Income Attributable To Owners of Parent | -NOK 72.1M | -NOK 35.3M |
| Current Financial Liabilities | NOK 14.7M | NOK 0 |
| Equity and Liabilities | NOK 112.6M | NOK 86.4M |
| Finance Income | NOK 12.2M | NOK 1.0M |
| Increase Decrease In Cash and Cash Equivalents | NOK 13.3M | NOK 715.0K |
| Increase Decrease Through Acquisition of Subsidiary | NOK 825.0K | — |
| Increase Decrease Through Sharebased Payment Transactions | NOK 3.8M | NOK 1.5M |
| Interest Paid Classified As Financing Activities | NOK 467.0K | NOK 195.0K |
| Investments In Subsidiaries | NOK 0 | NOK 0 |
| Issue of Equity | NOK 106.6M | NOK 42.5M |
| Issued Capital | NOK 82.4M | NOK 53.9M |
| Liabilities | NOK 38.6M | NOK 19.9M |
| Other Adjustments To Reconcile Profit Loss | -NOK 3.3M | -NOK 9.7M |
| Other Comprehensive Income | -NOK 320.0K | -NOK 70.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -NOK 320.0K | -NOK 70.0K |
| Other Current Assets | NOK 11.0M | NOK 11.7M |
| Other Current Liabilities | NOK 6.5M | NOK 5.3M |
| Other Expense By Nature | NOK 51.8M | NOK 19.5M |
| Other Noncurrent Liabilities | NOK 0 | NOK 2.9M |
| Other Reserves | NOK 7.7M | NOK 79.9M |
| Payments For Share Issue Costs | NOK 6.9M | NOK 3.1M |
| Proceeds From Issuing Shares | NOK 106.6M | NOK 42.5M |
| Purchase of Treasury Shares | NOK 53.0K | — |
| Revenue and Operating Income | NOK 9.7M | NOK 13.1M |
| Sale Or Issue of Treasury Shares | NOK 39.0K | — |
| Share Issue Related Cost | NOK 6.9M | — |
| Trade and Other Current Payables To Trade Suppliers | NOK 5.7M | NOK 3.6M |
Every line item above is a fact tagged in Lifecare ASA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (NOK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.